View in EDS PDF Full Text

Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

Saved in:
Bibliographic Details
Title: Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.
Authors: Bellmunt J; Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Juanpere N; Department of Pathology, Hospital del Mar, Barcelona, Spain., Munoz MG; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Kukreja S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Veiga SL; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Li R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Jiang Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Font-Tello A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Duarte MN; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Epstein I; Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hernández-Llodrà S; Department of Pathology, Hospital del Mar, Barcelona, Spain.; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Lorenzo M; Department of Pathology, Hospital del Mar, Barcelona, Spain., Menendez S; Department of Pathology, Hospital del Mar, Barcelona, Spain., Choueiri T; Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Brown M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Translational Oncology Laboratory, Hospital La Paz Institute for Health Research, (IdiPAZ), Madrid, Spain.
Source: Theranostics [Theranostics] 2026 May 18; Vol. 16 (12), pp. 6892-6910. Date of Electronic Publication: 2026 May 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42244999
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bellmunt+J%22">Bellmunt J</searchLink>; Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Xie+Y%22">Xie Y</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Juanpere+N%22">Juanpere N</searchLink>; Department of Pathology, Hospital del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Munoz+MG%22">Munoz MG</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Kukreja+S%22">Kukreja S</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Veiga+SL%22">Veiga SL</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Qiu+X%22">Qiu X</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Font-Tello+A%22">Font-Tello A</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Duarte+MN%22">Duarte MN</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Epstein+I%22">Epstein I</searchLink>; Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hernández-Llodrà+S%22">Hernández-Llodrà S</searchLink>; Department of Pathology, Hospital del Mar, Barcelona, Spain.; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lorenzo+M%22">Lorenzo M</searchLink>; Department of Pathology, Hospital del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Menendez+S%22">Menendez S</searchLink>; Department of Pathology, Hospital del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Choueiri+T%22">Choueiri T</searchLink>; Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Brown+M%22">Brown M</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Long+HW%22">Long HW</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Cejas+P%22">Cejas P</searchLink>; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Translational Oncology Laboratory, Hospital La Paz Institute for Health Research, (IdiPAZ), Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552395%22">Theranostics</searchLink> [Theranostics] 2026 May 18; Vol. 16 (12), pp. 6892-6910. <i>Date of Electronic Publication: </i>2026 May 18 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101552395 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1838-7640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218387640%22">18387640 </searchLink><i>NLM ISO Abbreviation: </i>Theranostics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42244999
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7150/thno.129729
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6892
    Titles:
      – TitleFull: Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bellmunt J
      – PersonEntity:
          Name:
            NameFull: Xie Y
      – PersonEntity:
          Name:
            NameFull: Juanpere N
      – PersonEntity:
          Name:
            NameFull: Munoz MG
      – PersonEntity:
          Name:
            NameFull: Kukreja S
      – PersonEntity:
          Name:
            NameFull: Veiga SL
      – PersonEntity:
          Name:
            NameFull: Li R
      – PersonEntity:
          Name:
            NameFull: Qiu X
      – PersonEntity:
          Name:
            NameFull: Jiang Y
      – PersonEntity:
          Name:
            NameFull: Font-Tello A
      – PersonEntity:
          Name:
            NameFull: Duarte MN
      – PersonEntity:
          Name:
            NameFull: Epstein I
      – PersonEntity:
          Name:
            NameFull: Hernández-Llodrà S
      – PersonEntity:
          Name:
            NameFull: Lorenzo M
      – PersonEntity:
          Name:
            NameFull: Menendez S
      – PersonEntity:
          Name:
            NameFull: Choueiri T
      – PersonEntity:
          Name:
            NameFull: Brown M
      – PersonEntity:
          Name:
            NameFull: Long HW
      – PersonEntity:
          Name:
            NameFull: Cejas P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 05
              Text: 2026 May 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1838-7640
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Theranostics
              Type: main
ResultId 1